tricaprin has been researched along with Hyperlipoproteinemia Type I in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Inadera, H; Kobayashi, J; Mori, S; Ohkubo, Y; Saito, Y; Shirai, K; Yoshida, S | 1 |
1 other study(ies) available for tricaprin and Hyperlipoproteinemia Type I
Article | Year |
---|---|
Type I hyperlipoproteinemia caused by lipoprotein lipase defect in lipid-interface recognition was relieved by administration of medium-chain triglyceride.
Topics: Adolescent; Carbon Radioisotopes; Chylomicrons; Dietary Fats; Excipients; Fatty Acids; Female; Heparin; Humans; Hydrolysis; Hyperlipoproteinemia Type I; Injections; Lipase; Lipids; Lipoprotein Lipase; Lipoproteins, VLDL; Liver; Octoxynol; Polyethylene Glycols; Triglycerides; Triolein | 1992 |